KeyBank National Association’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$99.8M Buy
108,458
+973
+0.9% +$986K 0.36% 60
2025
Q4
$116M Sell
107,485
-4,443
-4% -$4.25M 0.41% 51
2025
Q3
$85.4M Sell
111,928
-8,433
-7% -$6.28M 0.3% 67
2025
Q2
$93.8M Sell
120,361
-14,481
-11% -$11.3M 0.35% 60
2025
Q1
$111M Sell
134,842
-29,193
-18% -$24.3M 0.45% 49
2024
Q4
$127M Buy
164,035
+2,698
+2% +$2.23M 0.49% 40
2024
Q3
$143M Buy
161,337
+9,068
+6% +$8.15M 0.55% 35
2024
Q2
$138M Buy
152,269
+24,441
+19% +$19.6M 0.56% 36
2024
Q1
$99.4M Buy
127,828
+22,739
+22% +$16.2M 0.41% 58
2023
Q4
$61.3M Sell
105,089
-3,458
-3% -$2.02M 0.27% 80
2023
Q3
$58.3M Buy
108,547
+1,689
+2% +$870K 0.28% 76
2023
Q2
$50.1M Buy
106,858
+1,668
+2% +$700K 0.23% 95
2023
Q1
$36.1M Sell
105,190
-815
-0.8% -$275K 0.17% 117
2022
Q4
$38.8M Sell
106,005
-4,372
-4% -$1.55M 0.19% 113
2022
Q3
$35.7M Buy
110,377
+3,389
+3% +$1.07M 0.19% 110
2022
Q2
$34.7M Sell
106,988
-1,538
-1% -$462K 0.17% 123
2022
Q1
$31.1M Sell
108,526
-1,962
-2% -$505K 0.13% 141
2021
Q4
$30.5M Buy
110,488
+92
+0.1% +$23.3K 0.12% 142
2021
Q3
$25.5M Buy
110,396
+1,511
+1% +$373K 0.11% 147
2021
Q2
$25M Sell
108,885
-3,214
-3% -$646K 0.11% 149
2021
Q1
$20.9M Sell
112,099
-2,493
-2% -$488K 0.1% 158
2020
Q4
$19.3M Sell
114,592
-5,599
-5% -$836K 0.09% 157
2020
Q3
$17.8M Buy
120,191
+2,676
+2% +$414K 0.1% 149
2020
Q2
$19.3M Sell
117,515
-2,700
-2% -$414K 0.11% 139
2020
Q1
$16.7M Sell
120,215
-1,773
-1% -$244K 0.11% 140
2019
Q4
$16M Sell
121,988
-2,269
-2% -$263K 0.09% 163
2019
Q3
$13.9M Sell
124,257
-9,480
-7% -$1.06M 0.08% 174
2019
Q2
$14.8M Sell
133,737
-4,343
-3% -$511K 0.09% 173
2019
Q1
$17.9M Sell
138,080
-5,158
-4% -$627K 0.11% 156
2018
Q4
$16.6M Sell
143,238
-3,356
-2% -$375K 0.11% 151
2018
Q3
$15.7M Sell
146,594
-8,802
-6% -$880K 0.09% 168
2018
Q2
$13.3M Sell
155,396
-15,136
-9% -$1.24M 0.08% 177
2018
Q1
$13.2M Sell
170,532
-14,076
-8% -$1.13M 0.08% 179
2017
Q4
$15.6M Sell
184,608
-30,900
-14% -$2.63M 0.09% 169
2017
Q3
$18.4M Sell
215,508
-643
-0.3% -$52.7K 0.11% 156
2017
Q2
$17.8M Buy
216,151
+47,963
+29% +$3.91M 0.11% 153
2017
Q1
$14.1M Sell
168,188
-9,232
-5% -$739K 0.08% 172
2016
Q4
$13M Sell
177,420
-4,733
-3% -$352K 0.08% 171
2016
Q3
$14.6M Buy
182,153
+5,333
+3% +$427K 0.09% 159
2016
Q2
$13.9M Buy
176,820
+560
+0.3% +$42.2K 0.09% 162
2016
Q1
$12.7M Sell
176,260
-7,376
-4% -$558K 0.08% 163
2015
Q4
$15.5M Sell
183,636
-12,744
-6% -$1.06M 0.1% 155
2015
Q3
$16.4M Sell
196,380
-17,647
-8% -$1.49M 0.12% 150
2015
Q2
$17.9M Sell
214,027
-40,684
-16% -$3.1M 0.12% 146
2015
Q1
$18.5M Sell
254,711
-5,959
-2% -$424K 0.12% 143
2014
Q4
$18M Sell
260,670
-3,438
-1% -$232K 0.12% 145
2014
Q3
$17.1M Sell
264,108
-10,039
-4% -$636K 0.12% 152
2014
Q2
$17M Buy
274,147
+76,840
+39% +$4.58M 0.11% 155
2014
Q1
$11.6M Sell
197,307
-4,634
-2% -$259K 0.09% 178
2013
Q4
$10.3M Sell
201,941
-1,562
-0.8% -$78.2K 0.07% 186
2013
Q3
$10.2M Sell
203,503
-33,444
-14% -$1.75M 0.07% 191
2013
Q2
$11.6M Buy
+236,947
New +$12.9M 0.04% 407

Other funds holding LLY

KeyBank National Association's LLY Position: Q1 2026 in Review

KeyBank National Association increased its Eli Lilly (LLY) stake by 0.91% in Q1 2026, buying an estimated $986K and bringing the position to 108,458 shares worth $99.8M. The position accounts for 0.36% of the portfolio, ranked #60.

KeyBank National Association first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $143M in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • KeyBank National Association held 108,458 shares of Eli Lilly worth $99.8M as of Q1 2026.
  • KeyBank National Association bought 973 Eli Lilly shares in Q1 2026, an estimated $986K.
  • Eli Lilly made up 0.36% of KeyBank National Association's portfolio in Q1 2026, its #60 holding.
  • KeyBank National Association first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • KeyBank National Association's Eli Lilly position peaked at $143M in Q3 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on KeyBank National Association's 13F filing for Q1 2026, filed 24 Apr 2026.